These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 26169501)

  • 41. Hepatic steatosis in HIV-HCV coinfected patients: analysis of risk factors.
    Bani-Sadr F; Carrat F; Bedossa P; Piroth L; Cacoub P; Perronne C; Degott C; Pol S;
    AIDS; 2006 Feb; 20(4):525-31. PubMed ID: 16470116
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection.
    Petta S; Cammà C; Di Marco V; Alessi N; Cabibi D; Caldarella R; Licata A; Massenti F; Tarantino G; Marchesini G; Craxì A
    Am J Gastroenterol; 2008 May; 103(5):1136-44. PubMed ID: 18477344
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Elevated serum ferritin level associated with hepatic steatosis and fibrosis in hepatitis C virus-infected patients.
    Batsaikhan B; Gantumur G; Huang CI; Yeh ML; Huang CF; Lin ZY; Chen SC; Huang JF; Yu ML; Chuang WL; Lee JC; Dai CY
    J Chin Med Assoc; 2019 Feb; 82(2):99-104. PubMed ID: 30839498
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C.
    Miquilena-Colina ME; Lima-Cabello E; Sánchez-Campos S; García-Mediavilla MV; Fernández-Bermejo M; Lozano-Rodríguez T; Vargas-Castrillón J; Buqué X; Ochoa B; Aspichueta P; González-Gallego J; García-Monzón C
    Gut; 2011 Oct; 60(10):1394-402. PubMed ID: 21270117
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Hepatic steatosis in chronic hepatitis C: study of risk factors and relationship with the fibrosis stage].
    Antón MD; Roselló E; Gómez F; Paredes JM; López A; Moreno-Osset E
    Med Clin (Barc); 2009 Apr; 132(15):574-9. PubMed ID: 19368934
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Leptin levels in nonalcoholic steatohepatitis and chronic hepatitis C.
    Giannini E; Botta F; Cataldi A; Tenconi GL; Ceppa P; Barreca T; Testa R
    Hepatogastroenterology; 1999; 46(28):2422-5. PubMed ID: 10522010
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The extent of liver steatosis in chronic hepatitis C virus infection is mirrored by caspase activity in serum.
    Seidel N; Volkmann X; Länger F; Flemming P; Manns MP; Schulze-Osthoff K; Bantel H
    Hepatology; 2005 Jul; 42(1):113-20. PubMed ID: 15920717
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatic steatosis in chronic hepatitis B develops due to host metabolic factors: a comparative approach with genotype 1 chronic hepatitis C.
    Tsochatzis E; Papatheodoridis GV; Manesis EK; Chrysanthos N; Kafiri G; Archimandritis AJ
    Dig Liver Dis; 2007 Oct; 39(10):936-42. PubMed ID: 17720637
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum lipid profile and hepatic steatosis of adult beta-thalassaemia patients with chronic HCV infection.
    Siagris D; Kouraklis-Symeonidis A; Christofidou M; Lekkou A; Papadimitriou C; Arvaniti V; Thomopoulos K; Tsamandas A; Zoumbos N; Labropoulou-Karatza C
    Eur J Gastroenterol Hepatol; 2005 Mar; 17(3):345-50. PubMed ID: 15716660
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Steatohepatitis is associated with diabetes and fibrosis in genotype 1b HCV-related chronic liver disease.
    Masarone M; La Mura V; Bruno S; Gaeta GB; Vecchione R; Carrino F; Moschella F; Torella R; Persico M
    J Viral Hepat; 2007 Oct; 14(10):714-20. PubMed ID: 17875006
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum levels of adipokines in patients with chronic HCV infection: relationship with steatosis and fibrosis.
    Tiftikci A; Atug O; Yilmaz Y; Eren F; Ozdemir FT; Yapali S; Ozdogan O; Celikel CA; Imeryuz N; Tozun N
    Arch Med Res; 2009 May; 40(4):294-8. PubMed ID: 19608019
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity.
    Adinolfi LE; Gambardella M; Andreana A; Tripodi MF; Utili R; Ruggiero G
    Hepatology; 2001 Jun; 33(6):1358-64. PubMed ID: 11391523
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Decreased plasma adiponectin concentrations are closely related to steatosis in hepatitis C virus-infected patients.
    Petit JM; Minello A; Jooste V; Bour JB; Galland F; Duvillard L; Verges B; Olsson NO; Gambert P; Hillon P
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2240-3. PubMed ID: 15644404
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Apolipoprotein-AII concentrations are associated with liver steatosis in patients with chronic hepatitis C.
    Petit JM; Jooste V; Duvillard L; Minello A; Texier V; Galland F; Gambert P; Verges B; Hillon P
    Dig Dis Sci; 2007 Dec; 52(12):3431-4. PubMed ID: 17436096
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association between leptin, metabolic factors and liver histology in patients with chronic hepatitis C.
    Myers RP; Messous D; Poynard T; Imbert-Bismut F
    Can J Gastroenterol; 2007 May; 21(5):289-94. PubMed ID: 17505564
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatic steatosis and the risk of hepatocellular carcinoma in chronic hepatitis C.
    Kumar D; Farrell GC; Kench J; George J
    J Gastroenterol Hepatol; 2005 Sep; 20(9):1395-400. PubMed ID: 16105127
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis.
    Pekow JR; Bhan AK; Zheng H; Chung RT
    Cancer; 2007 Jun; 109(12):2490-6. PubMed ID: 17487861
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Factors associated with hepatic steatosis in human immunodeficiency virus and hepatits C virus coinfected patients].
    Pascual Pareja JF; Camino A; Larrauri J; López-Diéguez M; Montes ML; González-García J; Peña JM; Díez J; Arribas JR
    Med Clin (Barc); 2009 Feb; 132(6):208-13. PubMed ID: 19237003
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence and predictors of hepatic steatosis in adults with newly diagnosed chronic liver disease due to hepatitis C.
    Hayman AV; Sofair AN; Manos MM; Thomas A; Terrault N; Ness GV; Stabach N; Robert M; Rumore G; Corless C; Bell B; Bialek S; Zaman A
    Medicine (Baltimore); 2009 Sep; 88(5):302-306. PubMed ID: 19745689
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of insulin resistance on hepatic fibrosis and steatosis in hepatitis C virus (HCV) mono-infected compared with HIV-HCV co-infected patients.
    Halfon P; Pénaranda G; Carrat F; Bedossa P; Bourlière M; Ouzan D; Renou C; Tran A; Rosenthal E; Wartelle C; Delasalle P; Cacoub P
    Aliment Pharmacol Ther; 2009 Jul; 30(1):61-70. PubMed ID: 19292832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.